Literature DB >> 2872667

Megaloblastic anaemia due to sulphasalazine responding to drug withdrawal alone.

A Grieco, S Caputo, A Bertoli, P Caradonna, A V Greco.   

Abstract

A 60 year old man with ulcerative colitis since 1975 and treated with sulphasalazine, presented with severe megaloblastic anaemia caused by folate deficiency. The drug was stopped, and the anaemia recovered promptly. There was no relapse one year later.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872667      PMCID: PMC2418663          DOI: 10.1136/pgmj.62.726.307

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

1.  Megaloblastic anaemia associated with sulphasalazine treatment.

Authors:  R E Schneider; L Beeley
Journal:  Br Med J       Date:  1977-06-25

2.  Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.

Authors:  R E Pounder; E R Craven; J S Henthorn; J M Bannatyne
Journal:  Gut       Date:  1975-03       Impact factor: 23.059

3.  Megaloblastic anaemia associated with sulphasalazine treatment.

Authors:  S P Kane; M A Boots
Journal:  Br Med J       Date:  1977-11-12

4.  Inhibition of folate enzymes by sulfasalazine.

Authors:  J Selhub; G J Dhar; I H Rosenberg
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

Review 5.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

6.  Sulfasalazine inhibits the absorption of folates in ulcerative colitis.

Authors:  C H Halsted; G Gandhi; T Tamura
Journal:  N Engl J Med       Date:  1981-12-17       Impact factor: 91.245

7.  Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis.

Authors:  C M Swinson; J Perry; M Lumb; A J Levi
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

8.  Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine).

Authors:  J L Franklin; H H Rosenberg
Journal:  Gastroenterology       Date:  1973-04       Impact factor: 22.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.